Gastrointestinal stromal tumors (GISTs) are thought to originate from the interstitial cells of Cajal, which share many properties with neurons of the gastrointestinal tract. Recently, we demonstrated expression of the hormone ghrelin in GIST. The aim of the present study was therefore to evaluate a possible neuroendocrine phenotype of GIST. Specimens from 41 GISTs were examined for the expression of 12 different synaptic vesicle proteins. Expression of synaptic-like microvesicle proteins, e.g., Synaptic vesicle protein 2 (SV2), synaptobrevin, synapsin 1, and amphiphysin was demonstrated in a majority of GISTs by immunohistochemistry, western blotting, and quantitative reversetranscriptase PCR. One-third of the tumors also expressed the large dense core vesicle protein vesicular monoamine transporter 1. Presence of microvesicles and dense core vesicles in GIST was confirmed by electron microscopy. The expression of synaptic-like microvesicle proteins in GIST was not related to risk profile or to KIT/platelet derived growth factor alpha (PDGFRA) mutational status. Thus, GISTs regularly express a subset of synaptic-like microvesicle proteins necessary for the regulated secretion of neurotransmitters and hormones. Expression of synaptic-like micro-vesicle proteins, ghrelin and peptide hormone receptors in GIST indicate a neuroendocrine phenotype and suggest novel possibilities to treat therapy-resistant GIST.
Introduction
Gastrointestinal stromal tumors (GIST) are thought to originate from stem cells that differentiate toward the interstitial cells of Cajal (ICC; Kindblom et al. 1998 , Sircar et al. 1999 , Lee et al. 2001 . The ICC form a complex cellular network that is positioned between nerve endings and smooth muscle cells in the intestinal wall, and functions as a pacemaker system controlling motility and possibly also neurotransmission (Vannucchi 1999) . The tyrosine kinase receptor KIT is of vital importance for normal development of the intestinal pacemaker system (Huizinga et al. 1995 , Hirota et al. 1998 . Both ICC and GISTs express KIT, and mutations in the KIT gene are regarded as an early pathogenetic event in the tumorigenesis of GIST. Ultrastructural studies have demonstrated similarities between ICC and GISTs with presence of numerous cytoplasmic vesicles (Kindblom et al. 1998 , Komuro 1999 . GIST have dense core granules, or small empty vesicles, which resemble synaptic vesicles (Erlandson et al. 1996) .
Neuroendocrine function is defined by the presence of a regulated secretory pathway by which neurotransmitters and hormones are released upon stimulation. Two types of regulated secretory pathways have been characterized. One pathway utilizes large dense core vesicles (LDCVs) containing e.g. chromogranins, vesicular monamine transporters (VMAT 1 and 2), and synaptic vesicle protein 2 (SV2), and the other pathway uses synaptic-like microvesicles (SLMVs) containing e.g. synapsin 1, synaptophysin, synaptobrevin, and SV2 (Rindi et al. 2004) . Neurons predominantly contain SLMV, while neuroendocrine cells frequently contain both LDCV and SLMV.
Chromogranin A (CgA), the major acidic protein of chromaffin granules, is present in most neuroendocrine cell types, both normal and neoplastic (Lloyd & Wilson 1983) . The expression of synaptophysin, initially found in small vesicle membranes of neurons, has also been demonstrated in normal and neoplastic neuroendocrine cells (Jahn et al. 1985) . Expression of CgA and/or synaptophysin in tumors has therefore been used as histopathologic criterion for neuroendocrine differentiation.
Here, we report the expression profile of synaptic vesicle proteins, demonstrating regular presence of SLMV, but not of LDCV, in GIST.
Materials and methods

Criteria for GIST -diagnosis and classification
Criteria for the diagnosis of GIST were: (1) primary tumor site in the gastrointestinal tract and (2) characteristic histopathology including immunoreactivity toward KIT (CD 117). Based on tumor size and mitotic rate, the tumors were classified as very low-risk, low-risk, intermediate-risk, or high-risk GIST (Fletcher et al. 2002) . To these four risk groups, we added a fifth, overtly malignant, which included all tumors with proven metastases at the time of diagnosis (Nilsson et al. 2005 ). In the present study, we separated the tumors into low-risk profile (very low-, low-, and intermediate-risk GIST, nZ29) and high-risk profile (high-risk and overtly malignant GIST, nZ12).
Mutation analysis was performed on all 41 tumors as previously described (Andersson 2005) . The study was approved by the Ethical Trial Committee of Göteborg University and performed in accordance with the Helsinki Declaration of 1975.
Immunohistochemistry
Forty-one tumors (low-risk profile, nZ29; high-risk profile, nZ12) were analyzed by immunohistochemistry (IHC). Staining was performed on paraffinembedded specimens. In patients with low-risk profile GIST, 27 primaries, one local recurrence and one metastasis were used for analysis. In patients with high-risk profile GIST, seven primaries, one local recurrence, and four metastases were used for analysis. Sections (4 mm) were subjected to heat-induced antigen retrieval using microwave treatment (Tris-EDTA, pH 9). Details of primary antibodies are given in Table 1 . Bound antibodies were visualized using EnVisionCSystem-HRP labeled polymer (DakoCytomation, Dako, Glostrup, Denmark). Immunolabeling was graded as follows: 0, !1% positive tumor cells; 1C, 1-24% positive tumor cells; 2C, 25-75% positive tumor cells; 3C, O75% positive tumor cells. Normal tissue (brain and gut) and endocrine tumors (ileal carcinoid and adrenal pheochromocytoma) served as positive controls for IHC.
Confocal laser scanning microscopy
Formalin-fixed paraffin embedded specimens from normal stomach (nZ2), normal ileum (nZ2), normal colon (nZ2), and GIST (gastric; low-risk profile, nZ1 and high-risk profile, nZ2) were analyzed by confocal laser scanning microscopy. Sections (4 mm) were subjected to heat-induced antigen retrieval using microwave treatment (Tris-EDTA, pH 9) followed by incubation with a mixture of primary antibodies (anti-CD117 1:20 and anti-SV2 1:100), rinsing in PBS and incubated with a mixture of secondary antibodies conjugated with Alexa Fluor 594 (goat anti-rabbit, 1:2000; A11037, Invitrogen) and Alexa Fluor 488 (goat anti-mouse, 1:2000; A11029, Invitrogen, Carlsbad, CA, USA). Coverslips were mounted with ProLong Gold antifade reagent with DAPI (P36931, Molecular Probes, Eugene, OR, USA). The fluorescent cells were analyzed by confocal microscopy using a Zeiss LSM 510 META system with the LSM-FCS software supplied by the manufacturer (Carl Zeiss, Jena, Germany). Emission spectra were recorded with the META multichannel detector using the following settings: Hoechst 33258, Diode laser 405 nm excitation, 422-476 nm emission detection; Alexa Fluor 488, Argon laser 488 nm excitation, 497-550 nm emission detection and Alexa Fluor 594, DPSS-laser 561 nm excitation, 583-668 nm emission detection. Images were recorded with an optical section of 0.8 mm using a Plan-FLUAR 100X/1.45 N.A. oil immersion objective.
Electron microscopy
Specimens from GIST (gastric; low-risk profile, nZ1 and high-risk profile, nZ1) were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1-2 days, followed by postfixation in 1% osmium tetroxide for 1 h. Specimens were dehydrated and embedded in epoxy resin (TAAB 812). Ultrathin sections were placed on copper grids, contrasted with uranyl acetate and lead citrate before examination and photography in a Philips CM12 electron microscope.
Western blot
Biopsies from ten patients with GIST were analyzed by western blotting (low-risk profile, nZ4; high-risk profile, nZ6). In patients with low-risk profile GIST, only primary tumors were analyzed. In patients with high-risk profile GIST, one primary, one local P Bü mming et al.: Neuroendocrine differentiation in GIST www.endocrinology-journals.org recurrence and four metastases were used for analysis. Neuroendocrine tumors served as positive controls (sporadic adrenal pheochromocytoma, well-differentiated endocrine carcinoma of the ileum-midgut carcinoid, and sporadic endocrine pancreatic carcinoma-malignant insulinoma). Western blot was performed as previously described (Jakobsen et al. 2002) . Briefly, tumor tissues (200 mg/sample) were homogenized and assayed for protein content according to Bradford. Aliquots of proteins (40 mg) were separated by electrophoresis on precast polyacrylamide gels (10% NuPAGE Bis-Tris gels; Invitrogen) and transferred to polyvinyl difluoride membranes using a NOVEX blotting system (Invitrogen). The membranes were incubated with primary antibodies (Table 1) at C4 8C overnight, followed by incubation with alkaline phosphatase-conjugated secondary antibodies and then with CDP-Star (Tropix, Bedford, MA, USA) as substrate. The membranes were exposed to hyperfilm ECL (Amersham Pharmacia Biotech, Buckinghamshire, UK) at room temperature for 10-300 s. Molecular weight markers (See-Blue Plus 2 and MagicMark; Invitrogen) were used to calculate the apparent size of immunoreactive proteins.
Quantitative reverse transcriptase PCR (Q-PCR)
RNA extraction
Biopsies from ten patients with GIST were analyzed by Q-PCR (low-risk profile, nZ5; high-risk profile, cDNA synthesis cDNA was synthesized from extracted RNA using TaqMan reverse transcription reagents according to the manufacturer's protocol (Applied Biosystems, Foster City, CA, USA; cat. no. N808-0234). For every cDNA synthesis reaction, a control reaction containing the same components was run, but without reverse transcriptase. The tubes were placed in a GeneAmp PCR System 2400 (Applied Biosystems) and a onecycle PCR was performed using the following parameters: 25 8C for 10 min, 48 8C for 30 min, 95 8C for 5 min, followed by incubation at 4 8C. The cDNA was kept at K20 8C until assay.
Primers and probes
Primers and probes were purchased from Applied Biosystems. Hs00249911_m1 (vesicle-associated membrane protein 1: VAMP1; synaptobrevin 1), Hs00360269_m1 (vesicle-associated membrane protein 2: VAMP2; synaptobrevin 2), Hs00155723_m1 (amphiphysin: AMPH), Hs00199577_m1 (synapsin 1: SYN1), Hs00372069_m1 (synaptic vesicle glycoprotein 2A: SV2A), Hs00174029_m1 (v-kit: KIT), Hs00154441_ml (CgA: CHGA), Hs00300531_m1 (synaptophysin: SYP), Hs00161839_ml (vesicular monoamine, member 1: SLC18A1 solute carrier family 18: VMAT1), Hs00161858_ml (vesicular monoamine, member 2: SLC18A2 solute carrier family 18: VMAT2). b-Actin primers and probe were used as a control (TaqMan b-actin Control Reagent, cat. no. 401846).
Real-time PCR assay
The PCR assays were performed in 96-well optical plates with closed optical caps, using an ABI Prism 7700. A master mix was prepared for the PCR reactions, using 2! Assay Mix containing primers, probes and TaqMan Universal PCR Master Mix (part. no 4304437). (5, 6, 12, 6) 12/12 (0, 4, 8, 0) Synaptophysin 0/28 (28, 0, 0, 0) 0/9 (9, 0, 0, 0) Synapsin 2A 0/26 (26, 0, 0, 0) 0/10 (10, 0, 0, 0) Syntaxin 0/29 (29, 0, 0, 0) 0/12 (12, 0, 0, 0) SNAP25 0/29 (29, 0, 0, 0) 0/12 (12, 0, 0, 0) GAP43 0/29 (29, 0, 0, 0) 0/12 (12, 0, 0, 0) LDCV VMAT1 7/29 (22, 6, 1, 0) 6/12 (6, 2, 2, 2) VMAT2 0/29 (29, 0, 0, 0) 0/12 (12, 0, 0, 0) CgA 1/29 (28, 1, 0, 0) 0/12 (12, 0, 0, 0)
The results are given as the number of positive tumors/total number of tumors. Staining patterns were divided into four categories and the number of tumors in each category is given in parentheses (0, 1C, 2C, 3C). The categories were as follows: 0, !1% positive cells; 1C, 1-24% positive cells; 2C, 25-75% positive cells; 3C, O75% positive cells. Each well received 5 ml cDNA and 40 ml master mix. The samples were subjected to an initial heating for 2 min at 50 8C, followed by heating for 10 min. at 90 8C. The reaction consisted of 40 cycles of 95 8C for 15 s and 60 8C for 1 min. The samples were analyzed in triplicate.
The cycle threshold (C t ) for target genes and b-actin was determined for each sample. Values were expressed as KDC t (target gene: b-actin), or number of target copies per 1000 copies of b-actin.
Statistical analysis
Continuous data from the different groups were compared using the non-parametric Mann-Whitney U test. Categorical data from different groups were compared using Fisher's exact test. All P-values were two-tailed. P!0.05 was considered statistically significant.
Results
High-risk profile GIST was associated with tumor site in the small intestine (P!0.05), larger tumor size (P!0.001), and higher proliferation (Ki67max(%) and mitotic rate) (P!0.001). Clinicopathological data are given in detail in Table 2 .
Positive staining for KIT was observed in all GISTs (Table 3 , Fig. 1 ). Results of western blot showed that, in GISTs, KIT migrated as a major band with an apparent weight of 108 kDa, and with a minor band of w104 kDa (Fig. 2) . Q-PCR demonstrated high expression of KIT in all GISTs (Table 5 , Fig. 3 ). Activating KIT mutations were found in 27 (66%) out of 41 GISTs. There were no differences in overall KIT/PDGFRA mutation frequency between low-and high-risk profile GISTs. Details of KIT/ platelet derived growth factor alpha (PDGFRA) mutational analysis are given in Table 2 .
SLMV proteins are regularly expressed in GIST
SLMV proteins were shown to be expressed in GIST, as determined by IHC, western blot, and Q-PCR. Positive staining for SV2 was observed in the majority of GISTs (Table 3 ). In positive tumors, moderate to strong staining was observed in the cytoplasm of tumor cells, with a granular pattern (Fig. 1) . Western blot showed that SV2 migrates as a broad band of w75-100 kDa (Table 4, Fig. 2 ). Q-PCR showed expression of SV2A in all GISTs, with median values similar to those observed in well differentiated endocrine carcinomas (WDEC) of the ileum/carcinoids, and two orders of magnitude higher than those observed in colorectal adenocarcinomas (Table 5 and Fig. 3) . The localization of SV2 in GIST and normal ICC was further studied by confocal laser scanning microscopy (Fig. 4) . In GIST, a granular SV2 staining was observed in the cytoplasm of KIT positive tumor cells. In normal intestine, no SV2 staining could be detected in KIT positive ICC. However, a close spatial relationship between SV2 positive nerve terminals and KIT positive ICC was demonstrated.
Synapsin 1 was observed in the majority of GISTs (Table 3 ). In tumors, strong staining was seen predominantly in tumor cell neurite-and bouton-like structures (Fig. 1) . Q-PCR showed expression of synapsin 1 in all GISTs, with median values two orders of magnitude lower than those observed in WDEC of the ileum/carcinoids, but one order of magnitude higher than those observed in colorectal adenocarcinomas (Table 5 and Fig. 3 ).
Positive staining for amphiphysin was observed in the majority of GISTs (Table 3) . Moderate staining was seen in the majority of tumor cells, with a granular cytoplasmic pattern and frequently with perinuclear localization (Fig. 1) . In GISTs, amphiphysin migrated as multiple bands, with a major band of w85 kDa, and minor bands of 110, 120 and 155 kDa (Table 4 and Fig. 2 ). Q-PCR showed expression of amphiphysin in all GISTs with median values similar to those observed in WDEC of the ileum/carcinoids and one order of magnitude higher than those observed in colorectal adenocarcinomas (Table 5 and Fig. 3 ).
Positive staining for synaptobrevin was observed in the majority of GISTs (Table 3) . A moderate number of tumor cells were stained. Moderate staining with a granular pattern was seen in the tumor cell cytoplasm (Fig. 1) . In GISTs, synaptobrevin migrated as a major band of w15 kDa (Table 4 and Fig. 2 ). Q-PCR showed expression of synaptobrevin 1 and 2 in all GISTs. The expression values for synaptobrevin 2 were one order of magnitude higher than those for synaptobrevin 1. Expression values for synaptobrevin 1 and 2 in GISTs were similar to those in WDEC of the ileum/carcinoids (Table 5 and Fig. 3) .
Synaptophysin, synapsin 2A, syntaxin, SNAP-25, and GAP-43 could not be demonstrated by IHC, but expression of synaptophysin was detected by Q-PCR in all GISTs, although with median values two orders of magnitude lower than those observed in WDEC of the ileum/carcinoids and similar to those observed in colorectal adenocarcinomas.
LDCV proteins are not regularly expressed in GIST
LDCV proteins were demonstrated in a minority of GISTs (Table 3) . CgA was undetectable in all GISTs by IHC (Table 3) . Q-PCR showed expression of CgA in five GISTs, with median values five orders of magnitude lower than those in WDEC of the ileum/ carcinoids and similar to those observed in colorectal adenocarcinomas. VMAT1 was negative in the majority of GISTs, but a small number of tumor cells were stained in one-third of the tumors (Table 3) . Moderate staining was observed in the cytoplasm of tumor cells, predominantly localized to the perinuclear area ( Fig. 1 ). VMAT2 was undetectable in all GISTs by IHC. Western blot analysis was negative for both VMAT1 and VMAT2 (Table 4) . Q-PCR detected expression of VMAT1 in only two GISTs. The expression levels of VMAT 1, in these two tumors were four orders of magnitude lower than those observed in WDEC of the ileum/carcinoids, and similar to those observed in colorectal Figure 3 Scatter plots of KIT and synaptic vesicle protein expression in GISTs. Expression of SLMV markers (red) was higher than the expression of LDCV markers (blue). WDEC/midgut carcinoid ('carcinoid') and colorectal adenocarcinoma ('adenocarcinoma') served as control tumors. Log-transformed gene expression ratios obtained from Q-PCR analysis are plotted. Each dot represents data derived from one sample. Unfilled dots represent expression values below the detection limit. adenocarcinomas. Expression of VMAT 2 was detected in all but one GIST, with median values three orders of magnitude lower than those observed in WDEC of the ileum/carcinoids, and one order of magnitude lower than those observed in colorectal adenocarcinomas (Table 5 and Fig. 3 ).
Ultrastructural evidence for SLMV in GIST
Analysis of GIST by electron microscopy demonstrated presence of numerous vesicles in tumor cells. The majority of the vesicles was of clear type with an approximate diameter of 40-80 nm and located predominantly in perinuclear and Golgi areas. The ultrastructural appearance was consistent with that of SLMV. In some tumor cells, vesicles with an approximate diameter of 80-120 nm and an electron dense core were also demonstrated ( Fig. 5 ). 
Lack of correlation between expression of SLMV and clinicopathological features in GIST
There were no significant differences in the staining pattern, molecular size or expression levels of SLMV proteins when low-and high-risk profile GISTs were compared. Similarly, there were no significant differences in SLMV protein expression between GISTs with wild-type KIT/PDGFRA and mutated KIT/PDGFRA.
Discussion
Regulated secretion of transmitters and hormones is regarded as the hallmark of neuroendocrine cells and tumors. In addition, specific hormone production is frequently demonstrated in these tumors. In this study, we demonstrate expression of SV2, synaptobrevin, synapsin 1, and amphiphysin in a majority of GISTs regardless of tumor site, risk profile or KIT/PDGFRA mutational status. Expression of these SLMV proteins, in addition to ghrelin, and its receptor (Ekeblad et al. 2006 ), suggests and give evidence for a neuroendocrine phenotype. The diagnosis and classification of neuroendocrine tumors requires a combination of morphological analysis and demonstration of one or several of the synaptic vesicle protein known to be involved in the regulated secretory pathway. Traditionally, the presence of CgA and/or synaptophysin has been a prerequisite for the histopathological diagnosis of neuroendocrine tumors.
In recent years, multiple synaptic vesicle protein besides CgA and synaptophysin have been demonstrated in neuroendocrine tumors, e.g., SV2 (Portela-Gomes et al. 2000 , Jakobsen et al. 2002 , VMAT 1 and 2 (Jakobsen et al. 2001) , and amphiphysin (Zanner et al. 2004 ). The expression of several SLMV proteins in GIST therefore suggests that these tumors have a neural or neuroendocrine differentiation. This is further supported by the observation of numerous clear vesicles in GIST having an ultrastructural appearance of SLMV. 
